ArticleBMC pharmacology & toxicology2025
Unveiling the mechanistic links between plasticizers and gastric cancer via network toxicology and molecular docking approaches.
Article in BMC pharmacology & toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThis study explores the potential molecular mechanisms underlying the pathogenesis of gastric cancer induced by plasticizers, with particular emphasis on the interactions between plasticizers and key genes and signaling pathways. Methods: Machine learning algorithms were applied to multiple public datasets to identify potential target genes associated with gastric cancer. The interactions between plasticizers and target proteins were explored using network toxicology and molecular docking. Results: Our analysis identified 17 gastric cancer-related target genes associated with plasticizer exposure. Through machine learning optimization, the RF + Lasso model demonstrated superior performance (AUC: 0.816) and identified six core genes: CPB1, AKR1C1, GRM2, CA2, MMP7, and TDO2. Differential expression analysis revealed upregulation of GRM2, MMP7, and TDO2, alongside downregulation of CPB1, AKR1C1, and CA2 in gastric cancer tissues. Molecular docking confirmed specific binding interactions between plasticizers and target proteins, with binding energies ranging from − 6.4 to -11.2 kcal/mol. Conclusion: Our findings indicate that plasticizers may drive gastric cancer tumorigenesis by modulating key genes and signaling pathways. The molecular docking results indicate that there may be specific binding interactions between the target protein and plasticizers. This research establishes a platform for further probing the impact of plasticizers on gastric cancer development, offering conceptual guidance for forthcoming functional validation and targeted therapy development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.